Wednesday, July 30, 2014   

Cap removed for low-cost medicines
(05-08 12:36)

The retail price cap of low-cost medicines in China will be scrapped to revive dampened production caused by weak profits and ensure supply of essential drugs, the country's top economic planner and regulator announced Thursday.
Restriction on maximum prices of 280 Western medicines and 250 Chinese patent drugs, previously priced low by the government to relieve patients' medical burden, will be lifted, allowing producers to set prices according to their production costs, according to the National Development and Reform Commission, Xinhua news agency reports.
Chang Feng, director of the medicine price research department under China Medical University, said that the move, allowing the market to play a bigger role in deciding prices, will help motivate low-price medicine production and guarantee necessary supply.
The supply of low-price drugs has decreased as rising costs and shrinking demand made producers shift their attention to more profitable medicines, causing production of some first-aid medication including digoxin to be suspended.
The NDRC has asked local authorities to release a list of low-cost medicines to the public by July 1 and strengthen monitoring over unreasonable price lifting.   
Other China breaking news:
Microsoft under anti-monopoly probe (07-29 18:17)
Zhou Yongkang under probe (07-29 18:12)
China to put Glaxo investigators on trial (07-29 16:28)
Tighter crackdown on "naked officials" (07-29 16:10)
More flight delays expected (07-29 13:24)
Political advisor prosecuted for graft (07-29 11:21)
Century-old church down in fire (07-28 16:36)
China to begin military drill on Tuesday (07-28 15:19)
Xi wins mentions in state media: report (07-28 14:46)
Exhibition for North Korean defector artist called off (07-28 13:31)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.